Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance-Reference-Cited by-同舟云学术

Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance

Published:2022-12 Issue: Volume:41 Page:100645
ISSN:1755-4365
Container-title:Epidemics
language:en
Short-container-title:Epidemics

Author:

Donnici Claire^ORCID,Ilincic Natasha,Cao Christian,Zhang Caseng,Deveaux Gabriel,Clifton David,Buckeridge David,Bobrovitz Niklas,Arora Rahul K.

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Microbiology,Parasitology,Epidemiology

Reference28 articles.

1. SeroTracker: a global SARS-CoV-2 seroprevalence dashboard;Arora;Lancet Infect. Dis.,2021

2. Global epidemiology of SARS-CoV-2 infection: a systematic review and meta-analysis of standardized population-based seroprevalence studies, Jan 2020-Oct 2021 (preprint);Bergeri;Epidemiology,2021

3. Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis;Bobrovitz;PLoS ONE,2021

4. Bobrovitz, N., Noël, K., Li, Z., Cao, C., Deveaux, G., Selemon, A., Clifton, D.A., Yanes-Lane, M., Yan, T., Arora, R.K., 2022. SeroTracker-RoB: an approach to automating reproducible risk of bias assessment of seroprevalence studies. https://doi.org/10.1101/2021.11.17.21266471.

5. Reviewing the review process: identifying sources of delay;Cornelius;Australas. Med. J.,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence of SARS‐CoV‐2 Seroepidemiologic Studies to the ROSES‐S Reporting Guideline During the COVID‐19 Pandemic;Influenza and Other Respiratory Viruses;2024-07

2. Designing Surveillance at a Population Level;American Journal of Public Health;2023-11

3. Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response;The Lancet;2023-07

4. Adherence of SARS-CoV-2 seroepidemiologic studies to the ROSES-S reporting guideline during the COVID-19 pandemic;2023-06-05

5. Data needs for better surveillance and response to infectious disease threats;Epidemics;2023-06